Aurora Cannabis Strikes a Deal to Enter the U.S. CBD Market

Aurora Cannabis (NYSE: ACB) is making a long-awaited move into the largest legal cannabis market in the world. The marijuana producer announced on Wednesday that it has entered into an agreement to acquire Reliva, one of the best-selling retail cannabidiol (CBD) brands in the U.S.

Cannabidiol is one of the many compounds found in cannabis plants. Unlike marijuana, which tends to contain high levels of tetrahydrocannabinol (THC), CBD doesn't intoxicate users. Instead, a growing number of people in the U.S. and around the world use CBD products for their reported health benefits. In turn, retail CBD sales could grow to as much as $24 billion by 2025 in the U.S. alone, according to the Brightfield Group, a cannabis market researcher.

Reliva is a leading seller of hemp-derived CBD products in the U.S. Its products can be found in more than 20,000 retail stores across the country.

Source Fool.com